Related Experiment Video
Updated: Jul 2, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
Improved Glycemic Control through Robot-Assisted Remote Interview for Outpatients with Type 2 Diabetes: A Pilot Study
Kunimasa Yagi1,2, Michiko Inagaki3, Yuya Asada3
1Department of Internal Medicine, Kanazawa Medical University Hospital, Ishikawa 920-0293, Japan.
Medicina (Kaunas, Lithuania)
|February 24, 2024
Summary
Robot-assisted monitoring improved glycemic control in type 2 diabetes patients. Focusing on conversational content, not just naturalness, enhances system effectiveness for better diabetes management.
Area of Science:
- Biomedical Engineering
- Health Informatics
- Endocrinology
Background:
- A novel robot-assisted system was developed to aid Certified Diabetes Care and Education Specialists (CDCESs) in monitoring patients with type 2 diabetes (T2D).
- The system aims to support remote tracking of patient health status.
Purpose of the Study:
- To evaluate the impact of the robot-assisted system on glycemic control in patients with T2D.
- To identify patient characteristics suitable for utilizing this technology.
Main Methods:
- Remote interviews were conducted with T2D patients using the RoBoHoN robot after obtaining informed consent.
- Glycemic control was assessed via HbA1c levels at baseline and two months post-interview.
- Patients were categorized based on HbA1c targets; those with medication changes were excluded.
Main Results:
- Of 28 eligible patients, 8 improved glycemic control (1 inadequate to adequate, 7 inadequate to adequate).
- Multiple regression analysis indicated that clarity and naturalness of robot responses significantly contributed to glycemic control status.
- Focusing on conversational content, rather than superficial naturalness, is suggested for future system improvements.
Conclusions:
- The robot-assisted diabetes management system demonstrated efficacy in improving glycemic control.
- The study highlights the potential of technology in supporting diabetes self-management and patient care.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
283
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
283
01:16Insulin: Dosing Regimen and Adverse Effects
172
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
172
01:22Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K